AG James joined a bipartisan coalition of 50 attorneys general in urging consumers to check their eligibility for compensation as part of a $39.1 million settlement they secured with generic drug manufacturer Apotex Corp. (Apotex) for its role in a massive, long-running scheme to inflate prices of generic drugs and reduce competition. Attorney General James and the multistate coalition previously announced a settlement in principle with Apotex along with a $10 million settlement with Heritage Pharmaceuticals (Heritage). The settlements are part of an ongoing multistate investigation into companies for prescription drug price fixing. The companies in the scheme, some of which increased prices by 1,000 percent, manufactured essential medications to treat diseases ranging from diabetes to cancer to ADHD.

“When companies collude behind closed doors to raise prescription drug prices, they put everyday New Yorkers at serious risk. The companies involved in this scheme inflated prices of vital medications used to treat everything from diabetes and heart conditions to cancer, and now we are holding them accountable. I urge any New Yorker who may have been a victim of this scheme to check their eligibility and claim the restitution they are owed.” – AG James